Browsing by Author "XX676210"

Now showing items 1-7 of 7

    • Acute and fulminant hepatitis induced by flutamide: Case series report and review of the literature 
      Brahm Barril, Javier; Brahm, Magdalena; Segovia, Roberto; Buckel González, Erwin; Latorre, Ricardo; Poniachik Teller, Jaime; Zapata, Rodrigo; Contreras, Luis (MEXICAN ASSOC HEPATOLOGY, 2011)
      Flutamide is a non-steroidal anti-androgenic drug, commonly used in the treatment of advanced prostate cancer, acne and hirsutism. This drug may induce various degrees of liver injury, including acute liver failure (ALF), ...
    • Alemtuzumab Induction in Kidney Transplantation: Clinical Results and Impact on T-Regulatory Cells 
      Morales Peña, José; Bono Merino, María Rosa; Fierro, A.; Iñiguez, R.; Zehnder, C.; Rosemblatt Silber, Mario César; Calabran, L.; Herzog, C.; Benavente, D.; Aguiló, J.; Pefaur, J.; Alba, A.; Ferrario, M.; Simon, W.; Contreras, L.; Buckel González, Erwin (ELSEVIER SCIENCE INC, 2008-11)
      Alemtuzumab (ALT), a humanized monoclonal anti-CD52 antibody, was introduced in solid organ transplantation as an induction agent. ALT associated with anticalcineurins has provided a low incidence of acute rejection ...
    • Cirrosis biliar primaria: experiencia de trece años en dos centros de referencia 
      Valera M., José Miguel; Smok Sahid, Gladys; Poniachik Teller, Jaime; Oksenberg Reisberg, Danny; Silva P., Guillermo; Ferrario B., Mario; Buckel González, Erwin; Brahm Barril, Javier (2006)
      Background: Primary biliary cirrhosis (PBC) is a chronic cholestatic disease, which can progress to hepatic failure. Aim: To study the clinical presentation, pathological features, treatment and outcome of a group of ...
    • Evaluation of HLA Matchmaker Compatibility as Predictor of Graft Survival and Presence of Anti-HLA Antibodies 
      Silva, E.; Alba, A.; Castro, A.; Carrascal, M.; Buckel González, Erwin; Aguiló, J.; Herzog, C.; Calabrán, L.; Morales, J.; Fierro, J. A. (ELSEVIER, 2010)
      Background. HLA Matchmaker is a computer algorithm developed to evaluate donor/ receptor compatibility comparing sequences of polymorphic aminoacids (eplets) present in human leukocyte antigen (HLA) molecules. The aim ...
    • Hepatitis crónica y cirrosis por virus C pre y post trasplante hepático en una niña de 9 años 
      Alegría Quevedo, Sylvia Cecilia; Buckel González, Erwin; Ferrario B., Mario; Ceresa O., Sergio; Smok Sahid, Gladys; Brahm Barril, Javier (Sociedad Médica de Santiago, 2004-04)
      We report a girl with a chronic hepatitis caused by C virus diagnosed at the age of nine, unsuccessfully treated with interferon and ribavirine. Two years later, she was subjected to a liver transplantation. She maintained ...
    • Retiro precoz de esteroides en la inmunosupresión del trasplante renal pediátrico 
      Delucchi Bicocchi, María Angela; Valenzuela A., Marcela; Ferrario B., Mario; Lillo Durán, Ana; Guerrero G., José Luis; Rodríguez S., Eugenio; Cano Schuffeneger, Francisco; Cavada Chacón, Gabriel; Godoy L., Jorge; Rodríguez H., Jorge; González G., Gloria; Buckel González, Erwin; Contreras Meléndez, Luis (2006)
      Background: Cardiovascular risk, growth failure and the new immunosuppressive drugs, have encouraged steroid withdrawal or total avoidance with promising results in renal transplant (Tx) immunosuppression. Aim: To evaluate ...
    • Trasplante hepático en Chile: Aspectos generales, indicaciones y contraindicaciones (Documento de consenso) 
      Hepp, Juan; Zapata, Rodrigo; Buckel González, Erwin; Martínez, Jorge; Uribe Maturana, Mario; Díaz Jeraldo, Juan; Ferrario, Mario; Sanhueza, Edgar; Pérez, Rosa María; Hunter, Bessie; Ríos, Gloria; Humeres, Roberto; Poniachik Teller, Jaime; Oksenberg Reisberg, Dan; Arrese, Marco (SOC MEDICA SANTIAGO, 2008-06)
      Liver transplantation is an excellent therapeutic option for terminal liver disease, During the last decades the results of liver transplantation have improved significantly with a patient survival rate of nearly 90% at ...